US-funded biological laboratories in Ukraine were engaged in developing components of biological weapons, Deputy Chairman of the Russian Security Council Dmitry Medvedev has said.
"It is impossible not to mention the activities conducted by the US and its allies near the Russian borders," Medvedev said at a government meeting.
Such activities were not aimed at searching for effective means of protection against dangerous diseases or cooperating with the international community, he stressed, Xinhua news agency reported.
"Work there was carried out behind closed doors. In fact, components of biological weapons were developed and pathogenic microorganisms were studied that has posed a threat to all mankind," Medvedev said.
"Therefore, we consider such activities as a whole absolutely unacceptable both in Ukraine and other countries surrounding us," he said, adding that such activities should be transparent and under control.
--IANs
int/sks
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)